International Conference on Medicinal Chemistry and Enzyme Inhibitors

ICMCEI

15th Mar – 16th Mar 2027 Prague, Czech Republic

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Read the full Terms & Conditions

Registration Summary

Conference ICMCEI

Date 15th Mar – 16th Mar 2027

Location Prague, Czech Republic

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Advancements in Enzyme Inhibitor Design +

This track focuses on the latest methodologies in the design and development of enzyme inhibitors. Emphasis will be placed on structure-based drug design and the role of computational techniques in enhancing inhibitor efficacy.

SDG 3 SDG 4

02 Molecular Modeling in Drug Discovery +

This session will explore the application of molecular modeling techniques in the drug discovery process. Participants will discuss the integration of computational simulations with experimental data to optimize lead compounds.

SDG 3 SDG 9

03 Synthetic Methods in Medicinal Chemistry +

This track highlights innovative synthetic strategies employed in the creation of novel medicinal compounds. The focus will be on the development of efficient and sustainable synthetic routes to enhance drug availability.

SDG 9 SDG 12

04 Translational Research in Pharmacology +

This session aims to bridge the gap between laboratory research and clinical application in pharmacology. Discussions will center on the challenges and successes of translating preclinical findings into therapeutic interventions.

SDG 3 SDG 4

05 Chemical Biology Approaches in Drug Development +

This track will delve into the intersection of chemical biology and drug development. Participants will examine how chemical tools and techniques can elucidate biological mechanisms and inform therapeutic strategies.

SDG 3 SDG 9

06 Therapeutic Innovations in Enzyme Inhibition +

This session will focus on groundbreaking therapeutic innovations arising from enzyme inhibition research. Attendees will discuss novel inhibitors and their potential applications in treating various diseases.

SDG 3 SDG 4

07 Laboratory Techniques in Medicinal Chemistry +

This track will cover essential laboratory techniques utilized in medicinal chemistry research. Emphasis will be placed on methodologies that enhance the efficiency and accuracy of compound characterization and analysis.

SDG 3 SDG 9

08 Pharmacological Profiles of New Drug Candidates +

This session will investigate the pharmacological profiles of emerging drug candidates. Participants will discuss the importance of pharmacokinetics and pharmacodynamics in the evaluation of new therapeutic agents.

SDG 3 SDG 4

09 Biochemical Assays for Enzyme Inhibition +

This track will focus on the development and application of biochemical assays for evaluating enzyme inhibitors. The session will highlight innovative assay designs that improve the accuracy of inhibitor screening.

SDG 3 SDG 4

10 Regulatory Challenges in Drug Development +

This session will address the regulatory landscape surrounding drug development and the implications for medicinal chemistry. Discussions will focus on navigating the complexities of regulatory requirements in bringing new drugs to market.

SDG 3 SDG 16

11 Future Directions in Medicinal Chemistry Research +

This track will explore emerging trends and future directions in the field of medicinal chemistry. Participants will discuss the potential impact of new technologies and interdisciplinary approaches on drug discovery and development.

SDG 3 SDG 9